Modulation of 5-Fluorouracil with Methotrexate and Low-dose N-(phosphonacetyl)-l-aspartate in Patients with Advanced Colorectal Cancer. Results of a Phase II Study

Author： Kohne C.-H.   Harstrick A.   Hiddemann W.   Schoffski P.   Wilke H.   Bokemeyer C.   Dorken B.   Schmoll H.-J.  

Publisher： Elsevier

ISSN： 0959-8049

Source： European Journal of Cancer, Vol.33, Iss.11, 1997-10, pp. : 1896-1899

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Phase II Trial of N-(phosphonacetyl)-l-aspartate (PALA), 5-Fluorouracil and Recombinant Interferon- -2b in Patients with Advanced Gastric Carcinoma

By Wadler S.   Gleissner B.   Hilgenfeld R.U.   Thiel E.   Haynes H.   Kaleya R.   Rozenblit A.   Kreuser E.-D.  

European Journal of Cancer, Vol. 32, Iss. 7, 1996-06 ,pp. : 1254-1256

Elsevier

Access to resources Recommend Favorite

High-dose 5-fluorouracil plus low dose methotrexate plus or minus low-dose PALA in advanced colorectal cancer - a randomised phase II-III trial of the EORTC Gastrointestinal Group

By Wils J.   Blijham G.H.   Wagener T.   De Greve J.   Jansen R.L.H.   Kok T.C.   Nortier J.W.R.   Bleiberg H.   Couvreur M.L.   Genicot B.   Baron B.   on behalf of the EORTC Gastrointestinal Group  

European Journal of Cancer, Vol. 39, Iss. 3, 2003-02 ,pp. : 346-352

Elsevier

Access to resources Recommend Favorite

A phase II study of combined chemotherapy with methotrexate, 5-fluorouracil, and low-dose cisplatin (MFP) for histologically diffuse-type advanced and recurrent gastric cancer (KDOG9501)

By Nakayama Norisuke   Koizumi Wasaburo   Tanabe Satoshi   Sasaki Tohru   Saigenji Katsunori  

Gastric Cancer, Vol. 9, Iss. 3, 2006-08 ,pp. : 185-191

Springer Publishing Company

Access to resources Recommend Favorite

Biochemical modulation of 5-fluorouracil by leucovorin with or without interferon- -2c in patients with advanced colorectal cancer: final results of a randomised phase III study

By Hausmaninger H.   Moser R.   Samonigg H.   Mlineritsch B.   Schmidt H.   Pecherstorfer M.   Fridrik M.   Kopf C.   Nitsche D.   Kaider A.   Ludwig H.  

European Journal of Cancer, Vol. 35, Iss. 3, 1999-03 ,pp. : 380-385

Elsevier

Access to resources Recommend Favorite

High Dose 5-Fluorouracil (5-FU) and Folinic Acid in Advanced Colorectal Cancer Resistant to Standard Dose 5-FU Treatment: Results of a Phase II Study

By Jager E.   Klein O.   Wachter B.   Muller B.   Braun U.   Knuth A.  

European Journal of Cancer, Vol. 31, Iss. 10, 1995-09 ,pp. : 1717-1717

Elsevier

Access to resources Recommend Favorite